{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:24:36Z","timestamp":1787099076459,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["25K12010"],"award-info":[{"award-number":["25K12010"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The \u201cmesenchymal\u201d consensus molecular subtype 4 (CMS4) of colorectal cancer (CRC) has the poorest prognosis and shows stromal activation and bulk epithelial-mesenchymal transition (EMT) signatures that largely reflect cancer-associated fibroblast-derived signals, obscuring tumor cell-intrinsic programs. Aberrant glycosylation drives EMT and metastasis, yet the glycosyltransferase landscape intrinsic to CMS4 tumor epithelium remains poorly defined because stromal signals dominate bulk transcriptomes. To overcome this confounding, we analyzed single-cell RNA-sequencing datasets to distinguish CMS4 tumor epithelial cells from CMS1\u20133 epithelial cells, normal epithelium, and stromal\/immune populations. This identified a nine-gene glycosyltransferase signature uniquely upregulated in CMS4 tumor epithelium. Among these, GALNT5 showed consistent transcriptional induction during EMT in CRC cell lines. GALNT5 depletion suppressed proliferation, invasion, and migration, independent of overt changes in canonical EMT markers or AKT\/ERK signaling. Immunohistochemical analysis of 431 resected CRC specimens confirmed that GALNT5 protein expression was restricted to cancer cells, particularly at the invasive front. High GALNT5 expression was associated with deeper invasion and advanced stage, and served as an independent prognostic factor for worse overall survival, notably within the microsatellite-stable subgroup. In conclusion, by leveraging single-cell transcriptomics, this study defines a CMS4 epithelial-intrinsic glycosylation program and highlights GALNT5 as a prognostic biomarker and therapeutic candidate.<\/jats:p>","DOI":"10.1038\/s41598-026-57104-1","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:06:05Z","timestamp":1780905965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CMS4 epithelial-intrinsic glycosyltransferase GALNT5 promotes tumor aggressiveness and correlates with poor survival in colorectal cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Sohei","family":"Hayashishita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Okayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shotaro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuharu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiaki","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Matsuida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Katagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ujiie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Chida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenichiro","family":"Saze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosaku","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Momma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"57104_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"57104_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/ng.3225","volume":"47","author":"A Calon","year":"2015","unstructured":"Calon, A. et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet. 47, 320\u2013329. https:\/\/doi.org\/10.1038\/ng.3225 (2015).","journal-title":"Nat. Genet."},{"key":"57104_CR3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/ng.3224","volume":"47","author":"C Isella","year":"2015","unstructured":"Isella, C. et al. Stromal contribution to the colorectal cancer transcriptome. Nat. Genet. 47, 312\u2013319. https:\/\/doi.org\/10.1038\/ng.3224 (2015).","journal-title":"Nat. Genet."},{"key":"57104_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ccr.2012.08.013","volume":"22","author":"A Calon","year":"2012","unstructured":"Calon, A. et al. Dependency of colorectal cancer on a TGF-\u03b2-driven program in stromal cells for metastasis initiation. Cancer Cell. 22, 571\u2013584. https:\/\/doi.org\/10.1016\/j.ccr.2012.08.013 (2012).","journal-title":"Cancer Cell."},{"key":"57104_CR5","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"DVF Tauriello","year":"2018","unstructured":"Tauriello, D. V. F. et al. TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554, 538\u2013543. https:\/\/doi.org\/10.1038\/nature25492 (2018).","journal-title":"Nature"},{"key":"57104_CR6","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney, J. et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21, 1350\u20131356. https:\/\/doi.org\/10.1038\/nm.3967 (2015).","journal-title":"Nat. Med."},{"key":"57104_CR7","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-23-3964","volume":"30","author":"S Mouillet-Richard","year":"2024","unstructured":"Mouillet-Richard, S. et al. Clinical challenges of consensus molecular subtype CMS4 colon cancer in the era of precision medicine. Clin. Cancer Res. 30, 2351\u20132358. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-3964 (2024).","journal-title":"Clin. Cancer Res."},{"key":"57104_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1158\/1078-0432.CCR-16-0680","volume":"23","author":"A Trinh","year":"2017","unstructured":"Trinh, A. et al. Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry. Clin. Cancer Res. 23, 387\u2013398. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0680 (2017).","journal-title":"Clin. Cancer Res."},{"key":"57104_CR9","doi-asserted-by":"publisher","first-page":"745","DOI":"10.15252\/emmm.201606184","volume":"8","author":"E Fessler","year":"2016","unstructured":"Fessler, E. et al. TGFbeta signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype. EMBO Mol. Med. 8, 745\u2013760. https:\/\/doi.org\/10.15252\/emmm.201606184 (2016).","journal-title":"EMBO Mol. Med."},{"key":"57104_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/path.5155","volume":"246","author":"AM McCorry","year":"2018","unstructured":"McCorry, A. M., Loughrey, M. B., Longley, D. B., Lawler, M. & Dunne, P. D. Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition. J. Pathol. 246, 422\u2013426. https:\/\/doi.org\/10.1002\/path.5155 (2018).","journal-title":"J. Pathol."},{"key":"57104_CR11","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s41467-021-22800-1","volume":"12","author":"M Tyler","year":"2021","unstructured":"Tyler, M. & Tirosh, I. Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis. Nat. Commun. 12, 2592. https:\/\/doi.org\/10.1038\/s41467-021-22800-1 (2021).","journal-title":"Nat. Commun."},{"key":"57104_CR12","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1038\/s41598-023-28480-9","volume":"13","author":"PM Szabo","year":"2023","unstructured":"Szabo, P. M. et al. Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment. Sci. Rep. 13, 3051. https:\/\/doi.org\/10.1038\/s41598-023-28480-9 (2023).","journal-title":"Sci. Rep."},{"key":"57104_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc3982","volume":"15","author":"SS Pinho","year":"2015","unstructured":"Pinho, S. S. & Reis, C. A. Glycosylation in cancer: Mechanisms and clinical implications. Nat. Rev. Cancer. 15, 540\u2013555. https:\/\/doi.org\/10.1038\/nrc3982 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"57104_CR14","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.mam.2020.100905","volume":"79","author":"N Taniguchi","year":"2021","unstructured":"Taniguchi, N. et al. True significance of N-acetylglucosaminyltransferases GnT-III, V and alpha1,6 fucosyltransferase in epithelial-mesenchymal transition and cancer. Mol. Aspects Med. 79, 100905. https:\/\/doi.org\/10.1016\/j.mam.2020.100905 (2021).","journal-title":"Mol. Aspects Med."},{"key":"57104_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/bjc.2013.699","volume":"110","author":"M Hirakawa","year":"2014","unstructured":"Hirakawa, M. et al. Fucosylated TGF-beta receptors transduces a signal for epithelial-mesenchymal transition in colorectal cancer cells. Br. J. Cancer. 110, 156\u2013163. https:\/\/doi.org\/10.1038\/bjc.2013.699 (2014).","journal-title":"Br. J. Cancer"},{"key":"57104_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s13238-020-00741-7","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Ten Dijke, P., Wuhrer, M. & Zhang, T. Role of glycosylation in TGF-beta signaling and epithelial-to-mesenchymal transition in cancer. Protein Cell. 12, 89\u2013106. https:\/\/doi.org\/10.1007\/s13238-020-00741-7 (2021).","journal-title":"Protein Cell."},{"key":"57104_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/glycob\/cwac014","volume":"32","author":"J Beaman, E. M.","year":"2022","unstructured":"Beaman, E. M., Carter, D. R. F. & Brooks, S. A. GALNTs: Master regulators of metastasis-associated epithelial-mesenchymal transition (EMT)? Glycobiology 32, 556\u2013579 (2022). https:\/\/doi.org\/10.1093\/glycob\/cwac014","journal-title":"Glycobiology"},{"key":"57104_CR18","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"HO Lee","year":"2020","unstructured":"Lee, H. O. et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat. Genet. 52, 594\u2013603. https:\/\/doi.org\/10.1038\/s41588-020-0636-z (2020).","journal-title":"Nat. Genet."},{"key":"57104_CR19","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.CRC-25-0270","author":"H Suzuki","year":"2025","unstructured":"Suzuki, H. et al. GALNT7 stratifies dMMR\/MSI colorectal cancer into distinct molecular subsets associated with prognosis and PD-L1 expression. Cancer Res. Commun. https:\/\/doi.org\/10.1158\/2767-9764.CRC-25-0270 (2025).","journal-title":"Cancer Res. Commun."},{"key":"57104_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12935-024-03551-7","volume":"24","author":"Y Zhan","year":"2024","unstructured":"Zhan, Y. et al. N-acetylglucosaminyltransferase V drives colorectal cancer metastasis by facilitating ZO-1 ubiquitination and degradation. Cancer Cell. Int. 24, 366. https:\/\/doi.org\/10.1186\/s12935-024-03551-7 (2024).","journal-title":"Cancer Cell. Int."},{"key":"57104_CR21","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41416-020-0772-3","volume":"122","author":"R Gupta","year":"2020","unstructured":"Gupta, R. et al. Global analysis of human glycosyltransferases reveals novel targets for pancreatic cancer pathogenesis. Br. J. Cancer. 122, 1661\u20131672. https:\/\/doi.org\/10.1038\/s41416-020-0772-3 (2020).","journal-title":"Br. J. Cancer"},{"key":"57104_CR22","doi-asserted-by":"publisher","first-page":"e12100","DOI":"10.1016\/j.heliyon.2022.e12100","volume":"8","author":"T Zhao","year":"2022","unstructured":"Zhao, T. et al. Radiotherapy prognosis-associated gene GCNT3 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. Heliyon 8, e12100. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12100 (2022).","journal-title":"Heliyon"},{"key":"57104_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41419-020-03360-6","volume":"12","author":"C He","year":"2021","unstructured":"He, C. et al. The DDX39B\/FUT3\/TGFbetaR-I axis promotes tumor metastasis and EMT in colorectal cancer. Cell. Death Dis. 12, 74. https:\/\/doi.org\/10.1038\/s41419-020-03360-6 (2021).","journal-title":"Cell. Death Dis."},{"key":"57104_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10719-022-10041-3","volume":"39","author":"M Takahashi","year":"2022","unstructured":"Takahashi, M., Hasegawa, Y., Maeda, K., Kitano, M. & Taniguchi, N. Role of glycosyltransferases in carcinogenesis; growth factor signaling and EMT\/MET programs. Glycoconj. J. 39, 167\u2013176. https:\/\/doi.org\/10.1007\/s10719-022-10041-3 (2022).","journal-title":"Glycoconj. J."},{"key":"57104_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12079-022-00684-0","volume":"17","author":"QF Pan","year":"2023","unstructured":"Pan, Q. F. et al. Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-beta1\/SMAD3 and JNK axis activation. J. Cell. Commun. Signal. 17, 89\u2013102. https:\/\/doi.org\/10.1007\/s12079-022-00684-0 (2023).","journal-title":"J. Cell. Commun. Signal."},{"key":"57104_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13058-017-0904-8","volume":"19","author":"CF Tu","year":"2017","unstructured":"Tu, C. F., Wu, M. Y., Lin, Y. C., Kannagi, R. & Yang, R. B. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-beta receptor core fucosylation. Breast Cancer Res. 19, 111. https:\/\/doi.org\/10.1186\/s13058-017-0904-8 (2017).","journal-title":"Breast Cancer Res."},{"key":"57104_CR27","doi-asserted-by":"publisher","unstructured":"Agrawal, P. et al. A systems biology approach identifies FUT8 as a driver of melanoma metastasis. Cancer Cell 31, 804\u2013819 e807 (2017). https:\/\/doi.org\/10.1016\/j.ccell.2017.05.007","DOI":"10.1016\/j.ccell.2017.05.007"},{"key":"57104_CR28","doi-asserted-by":"publisher","unstructured":"Zhang, L. et al. Single-Cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell 181, 442\u2013459 e429 (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.03.048","DOI":"10.1016\/j.cell.2020.03.048"},{"key":"57104_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1158\/1078-0432.CCR-15-0876","volume":"22","author":"MP Mak","year":"2016","unstructured":"Mak, M. P. et al. A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition. Clin. Cancer Res. 22, 609\u2013620. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0876 (2016).","journal-title":"Clin. Cancer Res."},{"key":"57104_CR30","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1053\/j.gastro.2009.12.010","volume":"138","author":"MS Pino","year":"2010","unstructured":"Pino, M. S. et al. Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterology 138, 1406\u20131417. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.010 (2010).","journal-title":"Gastroenterology"},{"key":"57104_CR31","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/glycob\/cwz098","volume":"30","author":"M Detarya","year":"2020","unstructured":"Detarya, M. et al. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT\/ERK signaling. Glycobiology 30, 312\u2013324. https:\/\/doi.org\/10.1093\/glycob\/cwz098 (2020).","journal-title":"Glycobiology"},{"key":"57104_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. EMT: 2016. Cell 166, 21\u201345. https:\/\/doi.org\/10.1016\/j.cell.2016.06.028 (2016).","journal-title":"Cell"},{"key":"57104_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz, T., Kalluri, R., Nieto, M. A. & Weinberg, R. A. EMT in cancer. Nat. Rev. Cancer. 18, 128\u2013134. https:\/\/doi.org\/10.1038\/nrc.2017.118 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"57104_CR34","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.1158\/1078-0432.CCR-17-0023","volume":"23","author":"V Stiegelbauer","year":"2017","unstructured":"Stiegelbauer, V. et al. miR-196b-5p regulates colorectal cancer cell migration and metastases through interaction with HOXB7 and GALNT5. Clin. Cancer Res. 23, 5255\u20135266. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0023 (2017).","journal-title":"Clin. Cancer Res."},{"key":"57104_CR35","first-page":"4579","volume":"13","author":"J Yan","year":"2023","unstructured":"Yan, J. et al. GALNT5 functions as a suppressor of ferroptosis and a predictor of poor prognosis in pancreatic adenocarcinoma. Am. J. Cancer Res. 13, 4579\u20134596 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"57104_CR36","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41419-024-07110-w","volume":"15","author":"Q Jia","year":"2024","unstructured":"Jia, Q. et al. Oncogenic GALNT5 confers FOLFIRINOX resistance via activating the MYH9\/ NOTCH\/ DDR axis in pancreatic ductal adenocarcinoma. Cell. Death Dis. 15, 767. https:\/\/doi.org\/10.1038\/s41419-024-07110-w (2024).","journal-title":"Cell. Death Dis."},{"key":"57104_CR37","first-page":"4140","volume":"12","author":"M Detarya","year":"2022","unstructured":"Detarya, M. et al. Emerging roles of GALNT5 on promoting EGFR activation in cholangiocarcinoma: A mechanistic insight. Am. J. Cancer Res. 12, 4140\u20134159 (2022).","journal-title":"Am. J. Cancer Res."},{"key":"57104_CR38","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Schjoldager","year":"2020","unstructured":"Schjoldager, K. T., Narimatsu, Y., Joshi, H. J. & Clausen, H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell. Biol. 21, 729\u2013749. https:\/\/doi.org\/10.1038\/s41580-020-00294-x (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"57104_CR39","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41588-022-01100-4","volume":"54","author":"I Joanito","year":"2022","unstructured":"Joanito, I. et al. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nat. Genet. 54, 963\u2013975. https:\/\/doi.org\/10.1038\/s41588-022-01100-4 (2022).","journal-title":"Nat. Genet."},{"key":"57104_CR40","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas, N","year":"2012","unstructured":"Cancer Genome Atlas, N. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337. https:\/\/doi.org\/10.1038\/nature11252 (2012).","journal-title":"Nature"},{"key":"57104_CR41","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41591-023-02324-5","volume":"29","author":"J Roelands","year":"2023","unstructured":"Roelands, J. et al. An integrated tumor, immune and microbiome atlas of colon cancer. Nat. Med. 29, 1273\u20131286. https:\/\/doi.org\/10.1038\/s41591-023-02324-5 (2023).","journal-title":"Nat. Med."},{"key":"57104_CR42","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088 (2013).","journal-title":"Sci. Signal."},{"key":"57104_CR43","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"57104_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1564","author":"AK Thar Min","year":"2018","unstructured":"Thar Min, A. K. et al. Epithelial-mesenchymal transition-converted tumor cells can induce T-cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma. Cancer Med. https:\/\/doi.org\/10.1002\/cam4.1564 (2018).","journal-title":"Cancer Med."},{"key":"57104_CR45","doi-asserted-by":"publisher","first-page":"19234","DOI":"10.1038\/s41598-025-03924-6","volume":"15","author":"R Kanoda","year":"2025","unstructured":"Kanoda, R. et al. Downregulation of cGAS\/STING expression in tumor cells by cancer-associated fibroblasts in colorectal cancer. Sci. Rep. 15, 19234. https:\/\/doi.org\/10.1038\/s41598-025-03924-6 (2025).","journal-title":"Sci. Rep."},{"key":"57104_CR46","doi-asserted-by":"publisher","unstructured":"Japanese Society for Cancer of the, C. & & Rectum Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: The 3d English Edition [Secondary Publication]. J. Anus Rectum Colon. 3, 175\u2013195 https:\/\/doi.org\/10.23922\/jarc.2019-018 (2019).","DOI":"10.23922\/jarc.2019-018"},{"key":"57104_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/ags3.70159","author":"T Momma","year":"2025","unstructured":"Momma, T. et al. Prognostic impact of histologic subtypes in mismatch repair-deficient\/microsatellite instability-high colorectal cancer: A single-center retrospective study of 1127 stage 0\u2013IV patients. Ann. Gastroenterol. Surg. https:\/\/doi.org\/10.1002\/ags3.70159 (2025).","journal-title":"Ann. Gastroenterol. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57104-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57104-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:31:47Z","timestamp":1787095907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57104-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57104"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57104-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25985"}}